Pages that link to "Q44395938"
Jump to navigation
Jump to search
The following pages link to Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. (Q44395938):
Displaying 37 items.
- Inulin, a flexible oligosaccharide. II: Review of its pharmaceutical applications (Q26782865) (← links)
- Prime-boost approaches to tuberculosis vaccine development (Q27024526) (← links)
- Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine. (Q30358537) (← links)
- Development of stable influenza vaccine powder formulations: challenges and possibilities (Q30368221) (← links)
- Needle-free influenza vaccination. (Q30394326) (← links)
- Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution (Q33792946) (← links)
- ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. (Q35887431) (← links)
- In planta production of plant-derived and non-plant-derived adjuvants (Q37776716) (← links)
- Application and use of Inulin as a tool for therapeutic drug delivery (Q38012147) (← links)
- Delivery of antigens used for vaccination: recent advances and challenges. (Q38028969) (← links)
- Nanocarriers targeting dendritic cells for pulmonary vaccine delivery (Q38051096) (← links)
- Devices and formulations for pulmonary vaccination. (Q38115814) (← links)
- Nanocarriers: a versatile approach for mucosal vaccine delivery (Q38358876) (← links)
- Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant (Q38662873) (← links)
- Implications of plant glycans in the development of innovative vaccines (Q38738762) (← links)
- Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination (Q38818697) (← links)
- Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines? (Q38886698) (← links)
- Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation (Q38949613) (← links)
- Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals (Q39390000) (← links)
- Chitosan–interferon-β gene complex powder for inhalation treatment of lung metastasis in mice (Q39615807) (← links)
- Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant. (Q39770621) (← links)
- Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo. (Q40229866) (← links)
- Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model (Q40351285) (← links)
- Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus (Q41714862) (← links)
- Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. (Q43128462) (← links)
- Strategies for preventing influenza: future perspectives in influenza vaccine technology (Q44902406) (← links)
- "Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives". (Q44989827) (← links)
- Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization. (Q45367139) (← links)
- Developments in the formulation and delivery of spray dried vaccines (Q47106090) (← links)
- Intranasal immunization with dry powder vaccines (Q47584590) (← links)
- Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus (Q49943194) (← links)
- Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge (Q59352596) (← links)
- Nasal Dry Powder Vaccine Delivery Technology (Q62391112) (← links)
- Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization (Q64102134) (← links)
- Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles (Q85195094) (← links)
- Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination (Q92190091) (← links)
- Contemporary formulation development for inhaled pharmaceuticals (Q99357052) (← links)